Loading clinical trials...
Loading clinical trials...
Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain After Mini-abdominoplasty Surgery
Conditions
Interventions
CPL-01
Placebo
Locations
1
United States
Chesapeake Research Group
Pasadena, Maryland, United States
Start Date
January 6, 2020
Primary Completion Date
February 28, 2020
Completion Date
February 28, 2020
Last Updated
September 21, 2022
NCT06765772
NCT06601868
NCT05490602
NCT04902950
NCT04785638
NCT04785625
Lead Sponsor
Cali Pharmaceuticals LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions